Novel motif:30: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 14:39, 9 September 2013
name: | motif30_AGNTCC |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0003009 | skeletal muscle contraction | 6.203568e-16 |
GO:0043462 | regulation of ATPase activity | 1.233175e-15 |
GO:0007522 | visceral muscle development | 1.758500e-14 |
GO:0055009 | atrial cardiac muscle tissue morphogenesis | 8.666638e-12 |
GO:0051293 | establishment of spindle localization | 2.102125e-11 |
GO:0051298 | centrosome duplication | 2.349799e-10 |
GO:0045103 | intermediate filament-based process | 2.678637e-10 |
GO:0002579 | positive regulation of antigen processing and presentation | 4.052166e-10 |
GO:0045110 | intermediate filament bundle assembly | 9.628696e-10 |
GO:0045684 | positive regulation of epidermis development | 1.364389e-9 |
GO:0042074 | cell migration involved in gastrulation | 2.457977e-9 |
GO:0002026 | regulation of the force of heart contraction | 2.606542e-9 |
GO:0045104 | intermediate filament cytoskeleton organization | 2.841717e-9 |
GO:0006636 | unsaturated fatty acid biosynthetic process | 4.052569e-9 |
GO:0031444 | slow-twitch skeletal muscle fiber contraction | 4.528174e-9 |
GO:0010982 | regulation of high-density lipoprotein particle clearance | 4.693375e-9 |
GO:0006006 | glucose metabolic process | 5.230763e-9 |
GO:0009060 | aerobic respiration | 6.800687e-9 |
GO:0002606 | positive regulation of dendritic cell antigen processing and presentation | 7.860245e-9 |
GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 8.256244e-9 |
GO:0046456 | icosanoid biosynthetic process | 1.583462e-8 |
GO:0015742 | alpha-ketoglutarate transport | 1.836000e-8 |
GO:0002478 | antigen processing and presentation of exogenous peptide antigen | 2.015207e-8 |
GO:0009109 | coenzyme catabolic process | 2.212758e-8 |
GO:0071418 | cellular response to amine stimulus | 2.372582e-8 |
GO:0071417 | cellular response to organic nitrogen | 2.486443e-8 |
GO:0051005 | negative regulation of lipoprotein lipase activity | 2.843187e-8 |
GO:0000132 | establishment of mitotic spindle orientation | 3.273406e-8 |
GO:0046356 | acetyl-CoA catabolic process | 3.278578e-8 |
GO:0030262 | apoptotic nuclear change | 3.665109e-8 |
GO:0003229 | ventricular cardiac muscle tissue development | 4.095611e-8 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 4.683642e-8 |
GO:0010984 | regulation of lipoprotein particle clearance | 5.510597e-8 |
GO:0006099 | tricarboxylic acid cycle | 5.991377e-8 |
GO:0071230 | cellular response to amino acid stimulus | 8.801775e-8 |
GO:0051532 | regulation of NFAT protein import into nucleus | 9.020661e-8 |
GO:0040001 | establishment of mitotic spindle localization | 1.370130e-7 |
GO:0051187 | cofactor catabolic process | 1.465541e-7 |
GO:0019884 | antigen processing and presentation of exogenous antigen | 1.680750e-7 |
GO:0060621 | negative regulation of cholesterol import | 2.009474e-7 |
GO:0045109 | intermediate filament organization | 2.093518e-7 |
GO:0071229 | cellular response to acid | 2.410165e-7 |
GO:0071603 | endothelial cell-cell adhesion | 2.472503e-7 |
GO:0051956 | negative regulation of amino acid transport | 2.678188e-7 |
GO:0051534 | negative regulation of NFAT protein import into nucleus | 4.597017e-7 |
GO:0019318 | hexose metabolic process | 4.812180e-7 |
GO:0018023 | peptidyl-lysine trimethylation | 4.894390e-7 |
GO:0071421 | manganese ion transmembrane transport | 5.037783e-7 |
GO:0060620 | regulation of cholesterol import | 6.811420e-7 |
GO:0033700 | phospholipid efflux | 7.110287e-7 |
GO:0032233 | positive regulation of actin filament bundle assembly | 7.731863e-7 |
GO:0005996 | monosaccharide metabolic process | 9.543758e-7 |
GO:0010985 | negative regulation of lipoprotein particle clearance | 1.413741e-6 |
GO:0010987 | negative regulation of high-density lipoprotein particle clearance | 1.487815e-6 |
GO:0010897 | negative regulation of triglyceride catabolic process | 1.487815e-6 |
GO:0010901 | regulation of very-low-density lipoprotein particle remodeling | 1.663283e-6 |
GO:2000107 | negative regulation of leukocyte apoptosis | 1.938880e-6 |
GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter | 2.179127e-6 |
GO:0035691 | macrophage migration inhibitory factor signaling pathway | 2.179127e-6 |
GO:0001768 | establishment of T cell polarity | 2.502319e-6 |
GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 2.691559e-6 |
GO:0001661 | conditioned taste aversion | 2.743287e-6 |
GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation | 3.010877e-6 |
GO:0002037 | negative regulation of L-glutamate transport | 3.377375e-6 |
GO:0045994 | positive regulation of translational initiation by iron | 3.377375e-6 |
GO:0003056 | regulation of vascular smooth muscle contraction | 3.439607e-6 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 3.741804e-6 |
GO:0007127 | meiosis I | 4.088474e-6 |
GO:0001516 | prostaglandin biosynthetic process | 4.583176e-6 |
GO:0051303 | establishment of chromosome localization | 5.107600e-6 |
GO:0050703 | interleukin-1 alpha secretion | 5.441766e-6 |
GO:0085029 | extracellular matrix assembly | 5.729289e-6 |
GO:0090136 | epithelial cell-cell adhesion | 6.178601e-6 |
GO:0032780 | negative regulation of ATPase activity | 6.216531e-6 |
GO:0006921 | cellular component disassembly involved in apoptosis | 6.370170e-6 |
GO:0048243 | norepinephrine secretion | 6.844040e-6 |
GO:0032796 | uropod organization | 7.766761e-6 |
GO:0050881 | musculoskeletal movement | 8.696884e-6 |
GO:0045948 | positive regulation of translational initiation | 8.831249e-6 |
GO:0007398 | ectoderm development | 9.173741e-6 |
GO:0034442 | regulation of lipoprotein oxidation | 1.024015e-5 |
GO:0048251 | elastic fiber assembly | 1.039902e-5 |
GO:0002036 | regulation of L-glutamate transport | 1.044746e-5 |
GO:0034380 | high-density lipoprotein particle assembly | 1.096671e-5 |
GO:0051798 | positive regulation of hair follicle development | 1.127575e-5 |
GO:0045606 | positive regulation of epidermal cell differentiation | 1.194913e-5 |
GO:0042137 | sequestering of neurotransmitter | 1.343100e-5 |
GO:0042304 | regulation of fatty acid biosynthetic process | 1.355298e-5 |
GO:0051295 | establishment of meiotic spindle localization | 1.452873e-5 |
GO:0045618 | positive regulation of keratinocyte differentiation | 1.508587e-5 |
GO:0045922 | negative regulation of fatty acid metabolic process | 1.523806e-5 |
GO:0045717 | negative regulation of fatty acid biosynthetic process | 1.618729e-5 |
GO:0006105 | succinate metabolic process | 1.623825e-5 |
GO:0070715 | sodium-dependent organic cation transport | 1.753378e-5 |
GO:0060731 | positive regulation of intestinal epithelial structure maintenance | 1.753378e-5 |
GO:0052106 | quorum sensing involved in interaction with host | 1.753378e-5 |
GO:0006309 | DNA fragmentation involved in apoptotic nuclear change | 1.836926e-5 |
GO:0008078 | mesodermal cell migration | 1.888377e-5 |
GO:0033559 | unsaturated fatty acid metabolic process | 1.973049e-5 |
GO:0051926 | negative regulation of calcium ion transport | 2.101760e-5 |
GO:0007266 | Rho protein signal transduction | 2.120056e-5 |
GO:0006119 | oxidative phosphorylation | 2.194276e-5 |
GO:0033693 | neurofilament bundle assembly | 2.414810e-5 |
GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production | 2.414810e-5 |
GO:0007098 | centrosome cycle | 3.029641e-5 |
GO:0031330 | negative regulation of cellular catabolic process | 3.245196e-5 |
GO:0015874 | norepinephrine transport | 3.303981e-5 |
GO:0045060 | negative thymic T cell selection | 3.364645e-5 |
GO:0007132 | meiotic metaphase I | 3.405810e-5 |
GO:0002554 | serotonin secretion by platelet | 3.597239e-5 |
GO:0006094 | gluconeogenesis | 3.828607e-5 |
GO:0042891 | antibiotic transport | 4.004594e-5 |
GO:0002906 | negative regulation of mature B cell apoptosis | 4.004594e-5 |
GO:0071316 | cellular response to nicotine | 4.237584e-5 |
GO:0006360 | transcription from RNA polymerase I promoter | 4.374332e-5 |
GO:0034445 | negative regulation of plasma lipoprotein particle oxidation | 4.701057e-5 |
GO:0097039 | protein linear polyubiquitination | 5.111478e-5 |
GO:0015879 | carnitine transport | 5.257973e-5 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 5.288440e-5 |
GO:0051323 | metaphase | 5.501050e-5 |
GO:0006690 | icosanoid metabolic process | 5.537792e-5 |
GO:0003209 | cardiac atrium morphogenesis | 5.567919e-5 |
GO:0051952 | regulation of amine transport | 5.618625e-5 |
GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development | 6.102994e-5 |
GO:0031427 | response to methotrexate | 6.353075e-5 |
GO:0042775 | mitochondrial ATP synthesis coupled electron transport | 7.046179e-5 |
GO:0060052 | neurofilament cytoskeleton organization | 7.413974e-5 |
GO:0002903 | negative regulation of B cell apoptosis | 7.586418e-5 |
GO:0006596 | polyamine biosynthetic process | 7.668256e-5 |
GO:0045682 | regulation of epidermis development | 7.798748e-5 |
GO:0008033 | tRNA processing | 8.372415e-5 |
GO:0030046 | parallel actin filament bundle assembly | 8.695448e-5 |
GO:0030431 | sleep | 8.792105e-5 |
GO:0002876 | positive regulation of chronic inflammatory response to antigenic stimulus | 9.104180e-5 |
GO:0006007 | glucose catabolic process | 1.008954e-4 |
GO:0060251 | regulation of glial cell proliferation | 1.011802e-4 |
GO:0042711 | maternal behavior | 1.013412e-4 |
GO:0030213 | hyaluronan biosynthetic process | 1.028227e-4 |
GO:0018198 | peptidyl-cysteine modification | 1.032258e-4 |
GO:0010225 | response to UV-C | 1.047663e-4 |
GO:0048320 | axial mesoderm formation | 1.087736e-4 |
GO:0014028 | notochord formation | 1.151087e-4 |
GO:0035814 | negative regulation of renal sodium excretion | 1.214399e-4 |
GO:0070574 | cadmium ion transmembrane transport | 1.377455e-4 |
GO:0070229 | negative regulation of lymphocyte apoptosis | 1.443956e-4 |
GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling | 1.465556e-4 |
GO:0045604 | regulation of epidermal cell differentiation | 1.493092e-4 |
GO:0044070 | regulation of anion transport | 1.723772e-4 |
GO:0033344 | cholesterol efflux | 1.783361e-4 |
GO:0010452 | histone H3-K36 methylation | 1.798277e-4 |
GO:0003230 | cardiac atrium development | 1.824647e-4 |
GO:0003100 | regulation of systemic arterial blood pressure by endothelin | 1.938242e-4 |
GO:0070509 | calcium ion import | 1.949390e-4 |
GO:0045113 | regulation of integrin biosynthetic process | 1.995904e-4 |
GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway | 2.013029e-4 |
GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade | 2.138753e-4 |
GO:0045581 | negative regulation of T cell differentiation | 2.210168e-4 |
GO:0010624 | regulation of Schwann cell proliferation | 2.305646e-4 |
GO:2000465 | regulation of glycogen (starch) synthase activity | 2.344895e-4 |
GO:0000212 | meiotic spindle organization | 2.473063e-4 |
GO:0006505 | GPI anchor metabolic process | 2.488831e-4 |
GO:0031848 | protection from non-homologous end joining at telomere | 2.528209e-4 |
GO:0032202 | telomere assembly | 2.621031e-4 |
GO:0008089 | anterograde axon cargo transport | 2.621031e-4 |
GO:0043097 | pyrimidine nucleoside salvage | 2.644092e-4 |
GO:0006506 | GPI anchor biosynthetic process | 2.644219e-4 |
GO:0006447 | regulation of translational initiation by iron | 2.691649e-4 |
GO:0002740 | negative regulation of cytokine secretion involved in immune response | 2.720636e-4 |
GO:0034384 | high-density lipoprotein particle clearance | 2.776900e-4 |
GO:0045217 | cell-cell junction maintenance | 2.788161e-4 |
GO:0010873 | positive regulation of cholesterol esterification | 2.788161e-4 |
GO:0010625 | positive regulation of Schwann cell proliferation | 2.793113e-4 |
GO:0006544 | glycine metabolic process | 2.819462e-4 |
GO:0090281 | negative regulation of calcium ion import | 2.836512e-4 |
GO:0071584 | negative regulation of zinc ion import | 2.836512e-4 |
GO:0015969 | guanosine tetraphosphate metabolic process | 2.836512e-4 |
GO:0055090 | acylglycerol homeostasis | 2.849363e-4 |
GO:0032972 | regulation of muscle filament sliding speed | 2.849363e-4 |
GO:0002839 | positive regulation of immune response to tumor cell | 2.960229e-4 |
GO:0010989 | negative regulation of low-density lipoprotein particle clearance | 3.133589e-4 |
GO:0046626 | regulation of insulin receptor signaling pathway | 3.167740e-4 |
GO:0045943 | positive regulation of transcription from RNA polymerase I promoter | 3.241764e-4 |
GO:0032816 | positive regulation of natural killer cell activation | 3.244972e-4 |
GO:0045575 | basophil activation | 3.356431e-4 |
GO:0001694 | histamine biosynthetic process | 3.356431e-4 |
GO:0006349 | regulation of gene expression by genetic imprinting | 3.376554e-4 |
GO:0010388 | cullin deneddylation | 3.413611e-4 |
GO:0006828 | manganese ion transport | 3.487138e-4 |
GO:0007512 | adult heart development | 3.553881e-4 |
GO:0060730 | regulation of intestinal epithelial structure maintenance | 3.566024e-4 |
GO:0046339 | diacylglycerol metabolic process | 3.576982e-4 |
GO:0019370 | leukotriene biosynthetic process | 3.582980e-4 |
GO:0002027 | regulation of heart rate | 3.592487e-4 |
GO:0071514 | genetic imprinting | 3.669278e-4 |
GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process | 3.681086e-4 |
GO:0006066 | alcohol metabolic process | 3.724842e-4 |
GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin | 3.734846e-4 |
GO:0034969 | histone arginine methylation | 3.805368e-4 |
GO:0046645 | positive regulation of gamma-delta T cell activation | 3.841556e-4 |
GO:0070228 | regulation of lymphocyte apoptosis | 3.862231e-4 |
GO:0045061 | thymic T cell selection | 3.868957e-4 |
GO:0071874 | cellular response to norepinephrine stimulus | 3.892830e-4 |
GO:0010896 | regulation of triglyceride catabolic process | 4.001775e-4 |
GO:0051586 | positive regulation of dopamine uptake | 4.033746e-4 |
GO:0050433 | regulation of catecholamine secretion | 4.546800e-4 |
GO:0007509 | mesoderm migration involved in gastrulation | 4.674843e-4 |
GO:0045616 | regulation of keratinocyte differentiation | 4.684636e-4 |
GO:0050432 | catecholamine secretion | 4.919148e-4 |
GO:0051973 | positive regulation of telomerase activity | 5.037024e-4 |
GO:0022406 | membrane docking | 5.126304e-4 |
GO:0035269 | protein O-linked mannosylation | 5.223166e-4 |
GO:0019242 | methylglyoxal biosynthetic process | 5.223166e-4 |
GO:0010900 | negative regulation of phosphatidylcholine catabolic process | 5.223166e-4 |
GO:0006335 | DNA replication-dependent nucleosome assembly | 5.223166e-4 |
GO:0030212 | hyaluronan metabolic process | 5.226273e-4 |
GO:0043171 | peptide catabolic process | 5.238829e-4 |
GO:0050779 | RNA destabilization | 5.302299e-4 |
GO:0014807 | regulation of somitogenesis | 5.378879e-4 |
GO:0002367 | cytokine production involved in immune response | 5.452552e-4 |
GO:0007159 | leukocyte cell-cell adhesion | 5.495262e-4 |
GO:0010988 | regulation of low-density lipoprotein particle clearance | 5.499932e-4 |
GO:0060192 | negative regulation of lipase activity | 5.851970e-4 |
GO:0033314 | mitotic cell cycle DNA replication checkpoint | 5.890378e-4 |
GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II | 6.072164e-4 |
GO:0016233 | telomere capping | 6.072618e-4 |
GO:0051055 | negative regulation of lipid biosynthetic process | 6.101852e-4 |
GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling | 6.170575e-4 |
GO:0045333 | cellular respiration | 6.245068e-4 |
GO:0033590 | response to cobalamin | 6.489283e-4 |
GO:0006117 | acetaldehyde metabolic process | 6.489283e-4 |
GO:0033209 | tumor necrosis factor-mediated signaling pathway | 6.527030e-4 |
GO:0006691 | leukotriene metabolic process | 6.570495e-4 |
GO:0043954 | cellular component maintenance | 6.681494e-4 |
GO:0033505 | floor plate morphogenesis | 6.685185e-4 |
GO:0031647 | regulation of protein stability | 6.862268e-4 |
GO:0043585 | nose morphogenesis | 6.914447e-4 |
GO:0010872 | regulation of cholesterol esterification | 7.014240e-4 |
GO:0015809 | arginine transport | 7.063233e-4 |
GO:0051590 | positive regulation of neurotransmitter transport | 7.136106e-4 |
GO:0042823 | pyridoxal phosphate biosynthetic process | 7.159755e-4 |
GO:0006598 | polyamine catabolic process | 7.159755e-4 |
GO:0043353 | enucleate erythrocyte differentiation | 7.175731e-4 |
GO:0032926 | negative regulation of activin receptor signaling pathway | 7.241666e-4 |
GO:0060754 | positive regulation of mast cell chemotaxis | 7.317882e-4 |
GO:0014888 | striated muscle adaptation | 7.359708e-4 |
GO:0044342 | type B pancreatic cell proliferation | 7.469994e-4 |
GO:0010918 | positive regulation of mitochondrial membrane potential | 7.469994e-4 |
GO:0046628 | positive regulation of insulin receptor signaling pathway | 8.711704e-4 |
GO:0060346 | bone trabecula formation | 8.821655e-4 |
GO:0034723 | DNA replication-dependent nucleosome organization | 8.928931e-4 |
GO:0042157 | lipoprotein metabolic process | 9.044264e-4 |
GO:0060028 | convergent extension involved in axis elongation | 9.141696e-4 |
GO:0008625 | induction of apoptosis via death domain receptors | 9.218502e-4 |
GO:0000226 | microtubule cytoskeleton organization | 9.267416e-4 |
GO:0060370 | susceptibility to T cell mediated cytotoxicity | 9.310722e-4 |
GO:0015980 | energy derivation by oxidation of organic compounds | 9.420620e-4 |
GO:0002902 | regulation of B cell apoptosis | 9.430234e-4 |
GO:0042631 | cellular response to water deprivation | 9.762334e-4 |
GO:2000467 | positive regulation of glycogen (starch) synthase activity | 9.912420e-4 |
GO:0006734 | NADH metabolic process | 9.960749e-4 |
GO:0009895 | negative regulation of catabolic process | 9.962397e-4 |
GO:0015802 | basic amino acid transport | 1.003919e-3 |
GO:0070208 | protein heterotrimerization | 1.004880e-3 |
GO:0033235 | positive regulation of protein sumoylation | 1.021560e-3 |
GO:0042363 | fat-soluble vitamin catabolic process | 1.035109e-3 |
GO:0019233 | sensory perception of pain | 1.079068e-3 |
GO:0018364 | peptidyl-glutamine methylation | 1.089842e-3 |
GO:0031581 | hemidesmosome assembly | 1.097976e-3 |
GO:0051954 | positive regulation of amine transport | 1.128492e-3 |
GO:0065001 | specification of axis polarity | 1.142821e-3 |
GO:0006308 | DNA catabolic process | 1.186691e-3 |
GO:2000106 | regulation of leukocyte apoptosis | 1.197172e-3 |
GO:0014745 | negative regulation of muscle adaptation | 1.206798e-3 |
GO:0010983 | positive regulation of high-density lipoprotein particle clearance | 1.207367e-3 |
GO:0043503 | skeletal muscle fiber adaptation | 1.234884e-3 |
GO:0043091 | L-arginine import | 1.310123e-3 |
GO:0045342 | MHC class II biosynthetic process | 1.310123e-3 |
GO:0032632 | interleukin-3 production | 1.310123e-3 |
GO:0070839 | divalent metal ion export | 1.310123e-3 |
GO:0006876 | cellular cadmium ion homeostasis | 1.310123e-3 |
GO:0015707 | nitrite transport | 1.310123e-3 |
GO:0032226 | positive regulation of synaptic transmission, dopaminergic | 1.310123e-3 |
GO:0060381 | positive regulation of single-stranded telomeric DNA binding | 1.331056e-3 |
GO:0033605 | positive regulation of catecholamine secretion | 1.332215e-3 |
GO:0016142 | O-glycoside catabolic process | 1.334077e-3 |
GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine | 1.335377e-3 |
GO:0009186 | deoxyribonucleoside diphosphate metabolic process | 1.338975e-3 |
GO:0043588 | skin development | 1.345712e-3 |
GO:0044062 | regulation of excretion | 1.364784e-3 |
GO:0017121 | phospholipid scrambling | 1.375342e-3 |
GO:0002830 | positive regulation of type 2 immune response | 1.383653e-3 |
GO:0015697 | quaternary ammonium group transport | 1.408032e-3 |
GO:0097035 | regulation of membrane lipid distribution | 1.442254e-3 |
GO:0045005 | maintenance of fidelity involved in DNA-dependent DNA replication | 1.461339e-3 |
GO:0060005 | vestibular reflex | 1.484584e-3 |
GO:0043271 | negative regulation of ion transport | 1.490922e-3 |
GO:0043501 | skeletal muscle adaptation | 1.505642e-3 |
GO:0045980 | negative regulation of nucleotide metabolic process | 1.509041e-3 |
GO:0002860 | positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 1.527732e-3 |
GO:0019319 | hexose biosynthetic process | 1.576004e-3 |
GO:0006783 | heme biosynthetic process | 1.609647e-3 |
GO:0090086 | negative regulation of protein deubiquitination | 1.641451e-3 |
GO:0003108 | negative regulation of the force of heart contraction by chemical signal | 1.670525e-3 |
GO:0001692 | histamine metabolic process | 1.684082e-3 |
GO:0048752 | semicircular canal morphogenesis | 1.698843e-3 |
GO:0048733 | sebaceous gland development | 1.735148e-3 |
GO:0032418 | lysosome localization | 1.735148e-3 |
GO:0032231 | regulation of actin filament bundle assembly | 1.804632e-3 |
GO:0045588 | positive regulation of gamma-delta T cell differentiation | 1.859453e-3 |
GO:0030224 | monocyte differentiation | 1.879202e-3 |
GO:0006096 | glycolysis | 1.884077e-3 |
GO:0001702 | gastrulation with mouth forming second | 1.898810e-3 |
GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway | 1.901769e-3 |
GO:0032922 | circadian regulation of gene expression | 1.908976e-3 |
GO:0006540 | glutamate decarboxylation to succinate | 1.926578e-3 |
GO:0003065 | positive regulation of heart rate by epinephrine | 1.926578e-3 |
GO:2000974 | negative regulation of pro-B cell differentiation | 1.937699e-3 |
GO:0051988 | regulation of attachment of spindle microtubules to kinetochore | 1.937699e-3 |
GO:0051258 | protein polymerization | 1.948674e-3 |
GO:0060160 | negative regulation of dopamine receptor signaling pathway | 1.952961e-3 |
GO:0033003 | regulation of mast cell activation | 2.013547e-3 |
GO:0060872 | semicircular canal development | 2.020171e-3 |
GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly | 2.109981e-3 |
GO:0051580 | regulation of neurotransmitter uptake | 2.110852e-3 |
GO:0060026 | convergent extension | 2.145305e-3 |
GO:0006621 | protein retention in ER lumen | 2.161178e-3 |
GO:0045071 | negative regulation of viral genome replication | 2.179865e-3 |
GO:0022614 | membrane to membrane docking | 2.187725e-3 |
GO:0006501 | C-terminal protein lipidation | 2.198239e-3 |
GO:2000249 | regulation of actin cytoskeleton reorganization | 2.253775e-3 |
GO:0009438 | methylglyoxal metabolic process | 2.259469e-3 |
GO:0032367 | intracellular cholesterol transport | 2.270020e-3 |
GO:0042512 | negative regulation of tyrosine phosphorylation of Stat1 protein | 2.291801e-3 |
GO:0031272 | regulation of pseudopodium assembly | 2.300466e-3 |
GO:0019320 | hexose catabolic process | 2.314873e-3 |
GO:0042177 | negative regulation of protein catabolic process | 2.341724e-3 |
GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein | 2.347946e-3 |
GO:0030803 | negative regulation of cyclic nucleotide biosynthetic process | 2.354205e-3 |
GO:0050821 | protein stabilization | 2.438603e-3 |
GO:0035732 | nitric oxide storage | 2.450792e-3 |
GO:0071638 | negative regulation of monocyte chemotactic protein-1 production | 2.450792e-3 |
GO:0035726 | common myeloid progenitor cell proliferation | 2.450792e-3 |
GO:0016081 | synaptic vesicle docking involved in exocytosis | 2.456353e-3 |
GO:0014829 | vascular smooth muscle contraction | 2.458984e-3 |
GO:0010912 | positive regulation of isomerase activity | 2.461218e-3 |
GO:0006458 | 'de novo' protein folding | 2.472297e-3 |
GO:0006692 | prostanoid metabolic process | 2.474228e-3 |
GO:0006304 | DNA modification | 2.481126e-3 |
GO:0032862 | activation of Rho GTPase activity | 2.481946e-3 |
GO:0014738 | regulation of muscle hyperplasia | 2.505996e-3 |
GO:0060448 | dichotomous subdivision of terminal units involved in lung branching | 2.505996e-3 |
GO:0043985 | histone H4-R3 methylation | 2.505996e-3 |
GO:0051546 | keratinocyte migration | 2.545331e-3 |
GO:0000076 | DNA replication checkpoint | 2.545331e-3 |
GO:0006102 | isocitrate metabolic process | 2.545331e-3 |
GO:0042946 | glucoside transport | 2.556844e-3 |
GO:0070179 | D-serine biosynthetic process | 2.556844e-3 |
GO:0031619 | homologous chromosome orientation involved in meiotic metaphase I plate congression | 2.556844e-3 |
GO:0071956 | cellular component maintenance at cellular level | 2.570838e-3 |
GO:0051016 | barbed-end actin filament capping | 2.597542e-3 |
GO:0006108 | malate metabolic process | 2.616517e-3 |
GO:0006285 | base-excision repair, AP site formation | 2.633236e-3 |
GO:0070875 | positive regulation of glycogen metabolic process | 2.658010e-3 |
GO:0034224 | cellular response to zinc ion starvation | 2.661976e-3 |
GO:0006927 | transformed cell apoptosis | 2.683810e-3 |
GO:0031297 | replication fork processing | 2.704378e-3 |
GO:0044283 | small molecule biosynthetic process | 2.720334e-3 |
GO:0014707 | branchiomeric skeletal muscle development | 2.744669e-3 |
GO:0060707 | trophoblast giant cell differentiation | 2.756225e-3 |
GO:0034418 | urate biosynthetic process | 2.840351e-3 |
GO:0032365 | intracellular lipid transport | 2.848501e-3 |
GO:0000379 | tRNA-type intron splice site recognition and cleavage | 2.863333e-3 |
GO:0051927 | negative regulation of calcium ion transport via voltage-gated calcium channel activity | 2.929491e-3 |
GO:0060253 | negative regulation of glial cell proliferation | 2.936894e-3 |
GO:0035767 | endothelial cell chemotaxis | 2.942852e-3 |
GO:0043174 | nucleoside salvage | 3.021462e-3 |
GO:0045945 | positive regulation of transcription from RNA polymerase III promoter | 3.063793e-3 |
GO:0033233 | regulation of protein sumoylation | 3.088161e-3 |
GO:0046655 | folic acid metabolic process | 3.108906e-3 |
GO:0031274 | positive regulation of pseudopodium assembly | 3.108906e-3 |
GO:0046365 | monosaccharide catabolic process | 3.179402e-3 |
GO:0070327 | thyroid hormone transport | 3.208070e-3 |
GO:0003334 | keratinocyte development | 3.241824e-3 |
GO:0030826 | regulation of cGMP biosynthetic process | 3.280190e-3 |
GO:0045726 | positive regulation of integrin biosynthetic process | 3.298117e-3 |
GO:0051656 | establishment of organelle localization | 3.312504e-3 |
GO:0060035 | notochord cell development | 3.328600e-3 |
GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions | 3.328600e-3 |
GO:0072268 | pattern specification involved in metanephros development | 3.361066e-3 |
GO:0042104 | positive regulation of activated T cell proliferation | 3.362836e-3 |
GO:0009070 | serine family amino acid biosynthetic process | 3.375673e-3 |
GO:0015914 | phospholipid transport | 3.469600e-3 |
GO:0003208 | cardiac ventricle morphogenesis | 3.497390e-3 |
GO:0046364 | monosaccharide biosynthetic process | 3.536053e-3 |
GO:0016255 | attachment of GPI anchor to protein | 3.577972e-3 |
GO:0019221 | cytokine-mediated signaling pathway | 3.582061e-3 |
GO:0060460 | left lung morphogenesis | 3.680686e-3 |
GO:0048327 | axial mesodermal cell fate specification | 3.680686e-3 |
GO:0090010 | transforming growth factor beta receptor signaling pathway involved in primitive streak formation | 3.680686e-3 |
GO:0060802 | epiblast cell-extraembryonic ectoderm cell signaling involved in anterior/posterior axis specification | 3.680686e-3 |
GO:0002085 | inhibition of neuroepithelial cell differentiation | 3.680686e-3 |
GO:0016598 | protein arginylation | 3.680686e-3 |
GO:0034766 | negative regulation of ion transmembrane transport | 3.680686e-3 |
GO:0036006 | cellular response to macrophage colony-stimulating factor stimulus | 3.708434e-3 |
GO:0042699 | follicle-stimulating hormone signaling pathway | 3.752040e-3 |
GO:0019064 | viral envelope fusion with host membrane | 3.777119e-3 |
GO:0030818 | negative regulation of cAMP biosynthetic process | 3.779494e-3 |
GO:0032488 | Cdc42 protein signal transduction | 3.838954e-3 |
GO:0043383 | negative T cell selection | 3.864458e-3 |
GO:0032374 | regulation of cholesterol transport | 3.982876e-3 |
GO:0032964 | collagen biosynthetic process | 4.033612e-3 |
GO:0035813 | regulation of renal sodium excretion | 4.110107e-3 |
GO:0006527 | arginine catabolic process | 4.162223e-3 |
GO:0045620 | negative regulation of lymphocyte differentiation | 4.190245e-3 |
GO:0071394 | cellular response to testosterone stimulus | 4.190463e-3 |
GO:0045908 | negative regulation of vasodilation | 4.190463e-3 |
GO:0050689 | negative regulation of defense response to virus by host | 4.190463e-3 |
GO:0090197 | positive regulation of chemokine secretion | 4.226560e-3 |
GO:0006497 | protein lipidation | 4.229408e-3 |
GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway | 4.302751e-3 |
GO:0046466 | membrane lipid catabolic process | 4.316345e-3 |
GO:0030149 | sphingolipid catabolic process | 4.323229e-3 |
GO:0051496 | positive regulation of stress fiber assembly | 4.338344e-3 |
GO:0030823 | regulation of cGMP metabolic process | 4.340304e-3 |
GO:0060696 | regulation of phospholipid catabolic process | 4.353974e-3 |
GO:0048318 | axial mesoderm development | 4.417045e-3 |
GO:0051481 | reduction of cytosolic calcium ion concentration | 4.540622e-3 |
GO:0022411 | cellular component disassembly | 4.540784e-3 |
GO:0002861 | regulation of inflammatory response to antigenic stimulus | 4.541807e-3 |
GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process | 4.631057e-3 |
GO:0030300 | regulation of intestinal cholesterol absorption | 4.660043e-3 |
GO:0043200 | response to amino acid stimulus | 4.771980e-3 |
GO:0014044 | Schwann cell development | 4.801171e-3 |
GO:0051350 | negative regulation of lyase activity | 4.802817e-3 |
GO:0035518 | histone H2A monoubiquitination | 4.819801e-3 |
GO:0045074 | regulation of interleukin-10 biosynthetic process | 4.822657e-3 |
GO:0006882 | cellular zinc ion homeostasis | 4.822657e-3 |
GO:0072277 | metanephric glomerular capillary formation | 4.847146e-3 |
GO:0007231 | osmosensory signaling pathway | 4.847146e-3 |
GO:0018293 | protein-FAD linkage | 4.916764e-3 |
GO:0006121 | mitochondrial electron transport, succinate to ubiquinone | 4.916764e-3 |
GO:0035623 | renal glucose absorption | 4.919172e-3 |
GO:0000088 | mitotic prophase | 4.919172e-3 |
GO:0002522 | leukocyte migration involved in immune response | 4.919172e-3 |
GO:0002071 | glandular epithelial cell maturation | 4.931189e-3 |
GO:0014819 | regulation of skeletal muscle contraction | 4.934310e-3 |
GO:0030718 | germ-line stem cell maintenance | 4.958656e-3 |
GO:0061077 | chaperone-mediated protein folding | 4.960634e-3 |
GO:0009133 | nucleoside diphosphate biosynthetic process | 4.977672e-3 |
GO:0030321 | transepithelial chloride transport | 4.977672e-3 |
GO:0006284 | base-excision repair | 5.007916e-3 |
GO:2000651 | positive regulation of sodium ion transmembrane transporter activity | 5.008637e-3 |
GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus | 5.008637e-3 |
GO:0006633 | fatty acid biosynthetic process | 5.049331e-3 |
GO:0072385 | minus-end-directed organelle transport along microtubule | 5.063469e-3 |
GO:0007126 | meiosis | 5.106899e-3 |
GO:0035039 | male pronucleus assembly | 5.193297e-3 |
GO:0003062 | regulation of heart rate by chemical signal | 5.193297e-3 |
GO:0035104 | positive regulation of transcription via sterol regulatory element binding | 5.209721e-3 |
GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein | 5.215015e-3 |
GO:0001757 | somite specification | 5.215015e-3 |
GO:0035095 | behavioral response to nicotine | 5.224028e-3 |
GO:0048570 | notochord morphogenesis | 5.233881e-3 |
GO:0006091 | generation of precursor metabolites and energy | 5.329798e-3 |
GO:0043542 | endothelial cell migration | 5.390194e-3 |
GO:0050746 | regulation of lipoprotein metabolic process | 5.523893e-3 |
GO:0014059 | regulation of dopamine secretion | 5.530124e-3 |
GO:0006363 | termination of RNA polymerase I transcription | 5.565579e-3 |
GO:0090141 | positive regulation of mitochondrial fission | 5.595145e-3 |
GO:0090085 | regulation of protein deubiquitination | 5.595145e-3 |
GO:0006173 | dADP biosynthetic process | 5.599763e-3 |
GO:0051301 | cell division | 5.651019e-3 |
GO:0071577 | zinc ion transmembrane transport | 5.704574e-3 |
GO:0046340 | diacylglycerol catabolic process | 5.868299e-3 |
GO:0001842 | neural fold formation | 5.868299e-3 |
GO:0070389 | chaperone cofactor-dependent protein refolding | 5.871382e-3 |
GO:0006779 | porphyrin-containing compound biosynthetic process | 5.963177e-3 |
GO:0045872 | positive regulation of rhodopsin gene expression | 5.998487e-3 |
GO:0050983 | deoxyhypusine biosynthetic process from spermidine, using deoxyhypusine synthase | 5.998487e-3 |
GO:0031860 | telomeric 3' overhang formation | 5.998487e-3 |
GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation | 5.998487e-3 |
GO:0001916 | positive regulation of T cell mediated cytotoxicity | 6.079884e-3 |
GO:0046168 | glycerol-3-phosphate catabolic process | 6.092288e-3 |
GO:0018916 | nitrobenzene metabolic process | 6.092288e-3 |
GO:0060242 | contact inhibition | 6.112683e-3 |
GO:0033239 | negative regulation of cellular amine metabolic process | 6.112683e-3 |
GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity | 6.143984e-3 |
GO:0010986 | positive regulation of lipoprotein particle clearance | 6.143984e-3 |
GO:0001807 | regulation of type IV hypersensitivity | 6.143984e-3 |
GO:0060695 | negative regulation of cholesterol transporter activity | 6.232725e-3 |
GO:0015684 | ferrous iron transport | 6.232725e-3 |
GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway | 6.241526e-3 |
GO:0031947 | negative regulation of glucocorticoid biosynthetic process | 6.295448e-3 |
GO:0045065 | cytotoxic T cell differentiation | 6.329589e-3 |
GO:0006097 | glyoxylate cycle | 6.329589e-3 |
GO:0045819 | positive regulation of glycogen catabolic process | 6.520446e-3 |
GO:0031343 | positive regulation of cell killing | 6.571019e-3 |
GO:0051953 | negative regulation of amine transport | 6.581889e-3 |
GO:0060124 | positive regulation of growth hormone secretion | 6.638623e-3 |
GO:0072086 | specification of loop of Henle identity | 6.686761e-3 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0030488 | tRNA methylation | 6.572682e-14 |
GO:0050994 | regulation of lipid catabolic process | 4.120578e-11 |
GO:0015914 | phospholipid transport | 6.166009e-10 |
GO:0033700 | phospholipid efflux | 1.806762e-9 |
GO:0045833 | negative regulation of lipid metabolic process | 4.331087e-8 |
GO:0046890 | regulation of lipid biosynthetic process | 4.475269e-8 |
GO:0055090 | acylglycerol homeostasis | 5.137338e-8 |
GO:0034382 | chylomicron remnant clearance | 6.293638e-8 |
GO:0006705 | mineralocorticoid biosynthetic process | 9.938402e-8 |
GO:0001510 | RNA methylation | 1.588283e-7 |
GO:0032374 | regulation of cholesterol transport | 2.736056e-7 |
GO:0010896 | regulation of triglyceride catabolic process | 3.219567e-7 |
GO:0034660 | ncRNA metabolic process | 5.613584e-7 |
GO:0032049 | cardiolipin biosynthetic process | 6.241678e-7 |
GO:0042304 | regulation of fatty acid biosynthetic process | 8.367368e-7 |
GO:0070474 | positive regulation of uterine smooth muscle contraction | 1.180857e-6 |
GO:0045723 | positive regulation of fatty acid biosynthetic process | 1.396060e-6 |
GO:0043691 | reverse cholesterol transport | 1.460506e-6 |
GO:0016042 | lipid catabolic process | 1.764404e-6 |
GO:0010982 | regulation of high-density lipoprotein particle clearance | 2.180111e-6 |
GO:0070328 | triglyceride homeostasis | 2.547526e-6 |
GO:0010901 | regulation of very-low-density lipoprotein particle remodeling | 3.247590e-6 |
GO:0090207 | regulation of triglyceride metabolic process | 3.271618e-6 |
GO:0050995 | negative regulation of lipid catabolic process | 3.924901e-6 |
GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling | 4.163969e-6 |
GO:0032928 | regulation of superoxide anion generation | 4.448159e-6 |
GO:0051055 | negative regulation of lipid biosynthetic process | 4.572723e-6 |
GO:0010987 | negative regulation of high-density lipoprotein particle clearance | 4.974794e-6 |
GO:0010897 | negative regulation of triglyceride catabolic process | 4.974794e-6 |
GO:0060192 | negative regulation of lipase activity | 6.618768e-6 |
GO:0003009 | skeletal muscle contraction | 7.071043e-6 |
GO:0006400 | tRNA modification | 7.160917e-6 |
GO:0046889 | positive regulation of lipid biosynthetic process | 7.625349e-6 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 9.197108e-6 |
GO:0010985 | negative regulation of lipoprotein particle clearance | 9.708816e-6 |
GO:0010984 | regulation of lipoprotein particle clearance | 9.775360e-6 |
GO:0048630 | skeletal muscle tissue growth | 1.260311e-5 |
GO:0010989 | negative regulation of low-density lipoprotein particle clearance | 1.595815e-5 |
GO:0044062 | regulation of excretion | 1.748761e-5 |
GO:0051005 | negative regulation of lipoprotein lipase activity | 2.646560e-5 |
GO:0002642 | positive regulation of immunoglobulin biosynthetic process | 2.723768e-5 |
GO:0031536 | positive regulation of exit from mitosis | 2.794099e-5 |
GO:0050996 | positive regulation of lipid catabolic process | 3.027684e-5 |
GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway | 3.176871e-5 |
GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity | 3.252270e-5 |
GO:0033137 | negative regulation of peptidyl-serine phosphorylation | 3.656519e-5 |
GO:0035725 | sodium ion transmembrane transport | 3.761222e-5 |
GO:0061084 | negative regulation of protein refolding | 3.769449e-5 |
GO:0048642 | negative regulation of skeletal muscle tissue development | 3.856349e-5 |
GO:0006399 | tRNA metabolic process | 3.860618e-5 |
GO:0061098 | positive regulation of protein tyrosine kinase activity | 4.377846e-5 |
GO:0044240 | multicellular organismal lipid catabolic process | 4.601326e-5 |
GO:0033344 | cholesterol efflux | 5.169120e-5 |
GO:0035813 | regulation of renal sodium excretion | 5.342448e-5 |
GO:0007288 | sperm axoneme assembly | 6.039304e-5 |
GO:0065005 | protein-lipid complex assembly | 6.354018e-5 |
GO:0045931 | positive regulation of mitotic cell cycle | 6.499034e-5 |
GO:0071071 | regulation of phospholipid biosynthetic process | 6.550563e-5 |
GO:0018395 | peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine | 6.804195e-5 |
GO:0070078 | histone H3-R2 demethylation | 6.804195e-5 |
GO:0070079 | histone H4-R3 demethylation | 6.804195e-5 |
GO:0051725 | protein de-ADP-ribosylation | 6.804195e-5 |
GO:0035306 | positive regulation of dephosphorylation | 6.940724e-5 |
GO:0006878 | cellular copper ion homeostasis | 6.940724e-5 |
GO:0032048 | cardiolipin metabolic process | 7.674385e-5 |
GO:0034470 | ncRNA processing | 7.909807e-5 |
GO:0060621 | negative regulation of cholesterol import | 8.035796e-5 |
GO:0045834 | positive regulation of lipid metabolic process | 8.698090e-5 |
GO:0071072 | negative regulation of phospholipid biosynthetic process | 8.817176e-5 |
GO:0061014 | positive regulation of mRNA catabolic process | 8.860673e-5 |
GO:0032025 | response to cobalt ion | 8.973798e-5 |
GO:0009451 | RNA modification | 9.227333e-5 |
GO:0008652 | cellular amino acid biosynthetic process | 9.661598e-5 |
GO:0035307 | positive regulation of protein dephosphorylation | 9.863594e-5 |
GO:0007096 | regulation of exit from mitosis | 1.041585e-4 |
GO:0051261 | protein depolymerization | 1.067041e-4 |
GO:0032375 | negative regulation of cholesterol transport | 1.102987e-4 |
GO:0030431 | sleep | 1.138041e-4 |
GO:0060620 | regulation of cholesterol import | 1.186487e-4 |
GO:0055070 | copper ion homeostasis | 1.213468e-4 |
GO:0051004 | regulation of lipoprotein lipase activity | 1.235972e-4 |
GO:0010872 | regulation of cholesterol esterification | 1.239482e-4 |
GO:2000466 | negative regulation of glycogen (starch) synthase activity | 1.298820e-4 |
GO:0006520 | cellular amino acid metabolic process | 1.400843e-4 |
GO:0030263 | apoptotic chromosome condensation | 1.419087e-4 |
GO:0045940 | positive regulation of steroid metabolic process | 1.519610e-4 |
GO:0045988 | negative regulation of striated muscle contraction | 1.621507e-4 |
GO:0008033 | tRNA processing | 1.709276e-4 |
GO:0051481 | reduction of cytosolic calcium ion concentration | 1.769280e-4 |
GO:0032488 | Cdc42 protein signal transduction | 1.769280e-4 |
GO:0044106 | cellular amine metabolic process | 1.796740e-4 |
GO:0031444 | slow-twitch skeletal muscle fiber contraction | 1.862093e-4 |
GO:0032369 | negative regulation of lipid transport | 1.884742e-4 |
GO:0051323 | metaphase | 1.900186e-4 |
GO:0006982 | response to lipid hydroperoxide | 1.900186e-4 |
GO:0032368 | regulation of lipid transport | 1.971827e-4 |
GO:0090209 | negative regulation of triglyceride metabolic process | 2.066694e-4 |
GO:0045923 | positive regulation of fatty acid metabolic process | 2.277181e-4 |
GO:0000305 | response to oxygen radical | 2.330010e-4 |
GO:0032930 | positive regulation of superoxide anion generation | 2.347063e-4 |
GO:0006707 | cholesterol catabolic process | 2.373126e-4 |
GO:0045541 | negative regulation of cholesterol biosynthetic process | 2.384234e-4 |
GO:0000089 | mitotic metaphase | 2.428049e-4 |
GO:0032805 | positive regulation of low-density lipoprotein particle receptor catabolic process | 2.494627e-4 |
GO:0018364 | peptidyl-glutamine methylation | 2.494627e-4 |
GO:0055118 | negative regulation of cardiac muscle contraction | 2.566721e-4 |
GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process | 2.819129e-4 |
GO:0006481 | C-terminal protein methylation | 2.819129e-4 |
GO:0032849 | positive regulation of cellular pH reduction | 2.882183e-4 |
GO:0043648 | dicarboxylic acid metabolic process | 2.952221e-4 |
GO:0006549 | isoleucine metabolic process | 2.952866e-4 |
GO:0019217 | regulation of fatty acid metabolic process | 2.972766e-4 |
GO:0045218 | zonula adherens maintenance | 3.012432e-4 |
GO:0003012 | muscle system process | 3.049569e-4 |
GO:0006575 | cellular modified amino acid metabolic process | 3.127524e-4 |
GO:0045542 | positive regulation of cholesterol biosynthetic process | 3.344230e-4 |
GO:0009098 | leucine biosynthetic process | 3.367905e-4 |
GO:0006550 | isoleucine catabolic process | 3.367905e-4 |
GO:0010677 | negative regulation of cellular carbohydrate metabolic process | 3.500435e-4 |
GO:0010565 | regulation of cellular ketone metabolic process | 3.623451e-4 |
GO:0070050 | neuron homeostasis | 3.720788e-4 |
GO:0007099 | centriole replication | 4.018300e-4 |
GO:0045930 | negative regulation of mitotic cell cycle | 4.074935e-4 |
GO:0030300 | regulation of intestinal cholesterol absorption | 4.208503e-4 |
GO:0046600 | negative regulation of centriole replication | 4.503512e-4 |
GO:0006941 | striated muscle contraction | 4.552427e-4 |
GO:0006555 | methionine metabolic process | 4.874710e-4 |
GO:0021985 | neurohypophysis development | 5.175508e-4 |
GO:0006756 | AMP phosphorylation | 5.175508e-4 |
GO:0046092 | deoxycytidine metabolic process | 5.198188e-4 |
GO:0002432 | granuloma formation | 5.198188e-4 |
GO:0006573 | valine metabolic process | 5.515423e-4 |
GO:0030042 | actin filament depolymerization | 5.571523e-4 |
GO:0031998 | regulation of fatty acid beta-oxidation | 5.664801e-4 |
GO:0009296 | flagellum assembly | 5.833532e-4 |
GO:0061013 | regulation of mRNA catabolic process | 6.508370e-4 |
GO:0006448 | regulation of translational elongation | 6.973894e-4 |
GO:0034375 | high-density lipoprotein particle remodeling | 7.225926e-4 |
GO:0033979 | box H/ACA snoRNA metabolic process | 7.492805e-4 |
GO:0032900 | negative regulation of neurotrophin production | 7.492805e-4 |
GO:0032244 | positive regulation of nucleoside transport | 7.492805e-4 |
GO:0035414 | negative regulation of catenin import into nucleus | 7.836921e-4 |
GO:0051586 | positive regulation of dopamine uptake | 8.281560e-4 |
GO:0009309 | amine biosynthetic process | 8.352637e-4 |
GO:0055075 | potassium ion homeostasis | 8.477203e-4 |
GO:0031023 | microtubule organizing center organization | 8.529792e-4 |
GO:0010898 | positive regulation of triglyceride catabolic process | 8.698319e-4 |
GO:0032571 | response to vitamin K | 9.323511e-4 |
GO:0035814 | negative regulation of renal sodium excretion | 9.523469e-4 |
GO:0009308 | amine metabolic process | 9.583794e-4 |
GO:0007614 | short-term memory | 9.767542e-4 |
GO:0009086 | methionine biosynthetic process | 9.767542e-4 |
GO:0090141 | positive regulation of mitochondrial fission | 9.829516e-4 |
GO:0034959 | endothelin maturation | 9.829516e-4 |
GO:0010814 | substance P catabolic process | 9.829516e-4 |
GO:0010816 | calcitonin catabolic process | 9.829516e-4 |
GO:0048148 | behavioral response to cocaine | 1.018649e-3 |
GO:0032803 | regulation of low-density lipoprotein particle receptor catabolic process | 1.018649e-3 |
GO:0034436 | glycoprotein transport | 1.092962e-3 |
GO:0046874 | quinolinate metabolic process | 1.125711e-3 |
GO:0060056 | mammary gland involution | 1.198997e-3 |
GO:0000212 | meiotic spindle organization | 1.204268e-3 |
GO:0051299 | centrosome separation | 1.225784e-3 |
GO:0006103 | 2-oxoglutarate metabolic process | 1.292366e-3 |
GO:0070874 | negative regulation of glycogen metabolic process | 1.309965e-3 |
GO:0090049 | regulation of cell migration involved in sprouting angiogenesis | 1.389685e-3 |
GO:0042482 | positive regulation of odontogenesis | 1.389685e-3 |
GO:0046499 | S-adenosylmethioninamine metabolic process | 1.390036e-3 |
GO:0043314 | negative regulation of neutrophil degranulation | 1.448510e-3 |
GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway | 1.489823e-3 |
GO:0007525 | somatic muscle development | 1.500915e-3 |
GO:0051297 | centrosome organization | 1.526864e-3 |
GO:0006730 | one-carbon metabolic process | 1.544004e-3 |
GO:0006102 | isocitrate metabolic process | 1.585708e-3 |
GO:0010458 | exit from mitosis | 1.596551e-3 |
GO:0001845 | phagolysosome assembly | 1.616879e-3 |
GO:0043091 | L-arginine import | 1.666957e-3 |
GO:0032632 | interleukin-3 production | 1.666957e-3 |
GO:0070839 | divalent metal ion export | 1.666957e-3 |
GO:2000256 | positive regulation of male germ cell proliferation | 1.666957e-3 |
GO:0045342 | MHC class II biosynthetic process | 1.666957e-3 |
GO:0042231 | interleukin-13 biosynthetic process | 1.666957e-3 |
GO:0006121 | mitochondrial electron transport, succinate to ubiquinone | 1.666957e-3 |
GO:0018293 | protein-FAD linkage | 1.666957e-3 |
GO:0006876 | cellular cadmium ion homeostasis | 1.666957e-3 |
GO:0015761 | mannose transport | 1.666957e-3 |
GO:0015707 | nitrite transport | 1.666957e-3 |
GO:0052548 | regulation of endopeptidase activity | 1.695557e-3 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 1.722378e-3 |
GO:0006611 | protein export from nucleus | 1.734172e-3 |
GO:0010873 | positive regulation of cholesterol esterification | 1.744881e-3 |
GO:0000255 | allantoin metabolic process | 1.745507e-3 |
GO:0042136 | neurotransmitter biosynthetic process | 1.745507e-3 |
GO:0006546 | glycine catabolic process | 1.783233e-3 |
GO:0042095 | interferon-gamma biosynthetic process | 1.841603e-3 |
GO:0033590 | response to cobalamin | 1.841603e-3 |
GO:0050935 | iridophore differentiation | 1.887361e-3 |
GO:0048937 | lateral line nerve glial cell development | 1.887361e-3 |
GO:0031329 | regulation of cellular catabolic process | 1.975212e-3 |
GO:0043313 | regulation of neutrophil degranulation | 2.043249e-3 |
GO:0060712 | spongiotrophoblast layer development | 2.046725e-3 |
GO:0009992 | cellular water homeostasis | 2.112692e-3 |
GO:0045226 | extracellular polysaccharide biosynthetic process | 2.126080e-3 |
GO:0032513 | negative regulation of protein phosphatase type 2B activity | 2.126080e-3 |
GO:0051298 | centrosome duplication | 2.159360e-3 |
GO:0048711 | positive regulation of astrocyte differentiation | 2.159360e-3 |
GO:0045908 | negative regulation of vasodilation | 2.173701e-3 |
GO:0010815 | bradykinin catabolic process | 2.173701e-3 |
GO:0010447 | response to acidity | 2.184480e-3 |
GO:0032416 | negative regulation of sodium:hydrogen antiporter activity | 2.190888e-3 |
GO:0032796 | uropod organization | 2.244115e-3 |
GO:0046125 | pyrimidine deoxyribonucleoside metabolic process | 2.244115e-3 |
GO:0008612 | peptidyl-lysine modification to hypusine | 2.244115e-3 |
GO:0006659 | phosphatidylserine biosynthetic process | 2.336689e-3 |
GO:0019216 | regulation of lipid metabolic process | 2.395253e-3 |
GO:0007176 | regulation of epidermal growth factor-activated receptor activity | 2.537695e-3 |
GO:0090140 | regulation of mitochondrial fission | 2.719700e-3 |
GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway | 2.719700e-3 |
GO:0019218 | regulation of steroid metabolic process | 2.818724e-3 |
GO:0033211 | adiponectin-mediated signaling pathway | 2.821294e-3 |
GO:0043241 | protein complex disassembly | 2.855949e-3 |
GO:0000097 | sulfur amino acid biosynthetic process | 2.855949e-3 |
GO:0010724 | regulation of definitive erythrocyte differentiation | 2.985044e-3 |
GO:0045606 | positive regulation of epidermal cell differentiation | 2.993465e-3 |
GO:0006927 | transformed cell apoptosis | 2.993465e-3 |
GO:0008643 | carbohydrate transport | 3.090057e-3 |
GO:0006936 | muscle contraction | 3.149400e-3 |
GO:0035082 | axoneme assembly | 3.156991e-3 |
GO:0008625 | induction of apoptosis via death domain receptors | 3.156991e-3 |
GO:0030149 | sphingolipid catabolic process | 3.169058e-3 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 3.172133e-3 |
GO:0060005 | vestibular reflex | 3.360539e-3 |
GO:0002678 | positive regulation of chronic inflammatory response | 3.360539e-3 |
GO:0060706 | cell differentiation involved in embryonic placenta development | 3.365465e-3 |
GO:0046853 | inositol or phosphatidylinositol phosphorylation | 3.414804e-3 |
GO:0032862 | activation of Rho GTPase activity | 3.426793e-3 |
GO:0016081 | synaptic vesicle docking involved in exocytosis | 3.474884e-3 |
GO:0042254 | ribosome biogenesis | 3.593879e-3 |
GO:0006518 | peptide metabolic process | 3.669495e-3 |
GO:0006577 | betaine metabolic process | 3.707788e-3 |
GO:0034241 | positive regulation of macrophage fusion | 3.708514e-3 |
GO:0071169 | establishment of protein localization to chromatin | 3.708514e-3 |
GO:0032972 | regulation of muscle filament sliding speed | 3.708514e-3 |
GO:0032383 | regulation of intracellular cholesterol transport | 3.708514e-3 |
GO:0006427 | histidyl-tRNA aminoacylation | 3.708514e-3 |
GO:0032621 | interleukin-18 production | 3.708514e-3 |
GO:0033627 | cell adhesion mediated by integrin | 3.723921e-3 |
GO:0045618 | positive regulation of keratinocyte differentiation | 3.736755e-3 |
GO:0060177 | regulation of angiotensin metabolic process | 3.736755e-3 |
GO:0048484 | enteric nervous system development | 3.928037e-3 |
GO:0043064 | flagellum organization | 3.950028e-3 |
GO:0006998 | nuclear envelope organization | 4.090090e-3 |
GO:0051142 | positive regulation of NK T cell proliferation | 4.096167e-3 |
GO:0032057 | negative regulation of translational initiation in response to stress | 4.096167e-3 |
GO:0015670 | carbon dioxide transport | 4.109067e-3 |
GO:0010388 | cullin deneddylation | 4.109067e-3 |
GO:0034440 | lipid oxidation | 4.125310e-3 |
GO:0090208 | positive regulation of triglyceride metabolic process | 4.162314e-3 |
GO:0044242 | cellular lipid catabolic process | 4.192669e-3 |
GO:0050860 | negative regulation of T cell receptor signaling pathway | 4.271832e-3 |
GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway | 4.278729e-3 |
GO:0031331 | positive regulation of cellular catabolic process | 4.282650e-3 |
GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 4.317168e-3 |
GO:0032819 | positive regulation of natural killer cell proliferation | 4.388656e-3 |
GO:0051126 | negative regulation of actin nucleation | 4.461691e-3 |
GO:0048243 | norepinephrine secretion | 4.461691e-3 |
GO:0045624 | positive regulation of T-helper cell differentiation | 4.473871e-3 |
GO:0016072 | rRNA metabolic process | 4.483721e-3 |
GO:0045719 | negative regulation of glycogen biosynthetic process | 4.540861e-3 |
GO:0070327 | thyroid hormone transport | 4.555020e-3 |
GO:0042420 | dopamine catabolic process | 4.628779e-3 |
GO:0016075 | rRNA catabolic process | 4.628779e-3 |
GO:0045625 | regulation of T-helper 1 cell differentiation | 4.687295e-3 |
GO:0006646 | phosphatidylethanolamine biosynthetic process | 4.687295e-3 |
GO:0051006 | positive regulation of lipoprotein lipase activity | 4.746806e-3 |
GO:0045687 | positive regulation of glial cell differentiation | 4.810992e-3 |
GO:0010994 | free ubiquitin chain polymerization | 4.846883e-3 |
GO:0015669 | gas transport | 4.914636e-3 |
GO:0006487 | protein N-linked glycosylation | 4.931357e-3 |
GO:0007000 | nucleolus organization | 4.932154e-3 |
GO:0000302 | response to reactive oxygen species | 4.983075e-3 |
GO:0045136 | development of secondary sexual characteristics | 4.998037e-3 |
GO:0051403 | stress-activated MAPK cascade | 5.024294e-3 |
GO:0006693 | prostaglandin metabolic process | 5.118737e-3 |
GO:0006578 | betaine biosynthetic process | 5.186575e-3 |
GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis | 5.186575e-3 |
GO:0034370 | triglyceride-rich lipoprotein particle remodeling | 5.252475e-3 |
GO:0046466 | membrane lipid catabolic process | 5.308584e-3 |
GO:0002740 | negative regulation of cytokine secretion involved in immune response | 5.332825e-3 |
GO:0042481 | regulation of odontogenesis | 5.368453e-3 |
GO:0007098 | centrosome cycle | 5.384108e-3 |
GO:0034369 | plasma lipoprotein particle remodeling | 5.429933e-3 |
GO:0048846 | axon extension involved in axon guidance | 5.461673e-3 |
GO:0051336 | regulation of hydrolase activity | 5.467062e-3 |
GO:0060137 | maternal process involved in parturition | 5.665413e-3 |
GO:0055099 | response to high density lipoprotein particle stimulus | 5.665413e-3 |
GO:0048280 | vesicle fusion with Golgi apparatus | 5.665413e-3 |
GO:0032929 | negative regulation of superoxide anion generation | 5.750652e-3 |
GO:0019751 | polyol metabolic process | 5.835644e-3 |
GO:0034763 | negative regulation of transmembrane transport | 5.854711e-3 |
GO:2000974 | negative regulation of pro-B cell differentiation | 5.865758e-3 |
GO:0008633 | activation of pro-apoptotic gene products | 6.219247e-3 |
GO:0046940 | nucleoside monophosphate phosphorylation | 6.258550e-3 |
GO:0045110 | intermediate filament bundle assembly | 6.258550e-3 |
GO:0021979 | hypothalamus cell differentiation | 6.258550e-3 |
GO:0009817 | defense response to fungus, incompatible interaction | 6.258550e-3 |
GO:0030049 | muscle filament sliding | 6.310658e-3 |
GO:0010519 | negative regulation of phospholipase activity | 6.352987e-3 |
GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 6.352987e-3 |
GO:0051865 | protein autoubiquitination | 6.374077e-3 |
GO:0050748 | negative regulation of lipoprotein metabolic process | 6.408802e-3 |
GO:0006612 | protein targeting to membrane | 6.486231e-3 |
GO:0061097 | regulation of protein tyrosine kinase activity | 6.488065e-3 |
GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | 6.545191e-3 |
GO:0048880 | sensory system development | 6.627062e-3 |
GO:0046470 | phosphatidylcholine metabolic process | 6.753271e-3 |
GO:0070389 | chaperone cofactor-dependent protein refolding | 6.779664e-3 |
GO:0018126 | protein hydroxylation | 6.799300e-3 |
GO:0043278 | response to morphine | 6.845275e-3 |
GO:0050881 | musculoskeletal movement | 6.907881e-3 |
GO:0055009 | atrial cardiac muscle tissue morphogenesis | 6.970806e-3 |
GO:0031589 | cell-substrate adhesion | 7.133738e-3 |
GO:0006970 | response to osmotic stress | 7.136240e-3 |
GO:0032000 | positive regulation of fatty acid beta-oxidation | 7.150926e-3 |
GO:0006414 | translational elongation | 7.237023e-3 |
GO:0045932 | negative regulation of muscle contraction | 7.289949e-3 |
GO:0051168 | nuclear export | 7.739520e-3 |
GO:0021892 | cerebral cortex GABAergic interneuron differentiation | 7.797347e-3 |
GO:0071593 | lymphocyte aggregation | 7.881628e-3 |
GO:0006668 | sphinganine-1-phosphate metabolic process | 7.881628e-3 |
GO:0042660 | positive regulation of cell fate specification | 7.881628e-3 |
GO:0000303 | response to superoxide | 7.946588e-3 |
GO:0055091 | phospholipid homeostasis | 8.033103e-3 |
GO:0050856 | regulation of T cell receptor signaling pathway | 8.052561e-3 |
GO:2000429 | negative regulation of neutrophil aggregation | 8.250321e-3 |
GO:0021528 | commissural neuron differentiation in spinal cord | 8.250321e-3 |
GO:0071638 | negative regulation of monocyte chemotactic protein-1 production | 8.250321e-3 |
GO:2000469 | negative regulation of peroxidase activity | 8.250321e-3 |
GO:0035726 | common myeloid progenitor cell proliferation | 8.250321e-3 |
GO:0043128 | positive regulation of 1-phosphatidylinositol 4-kinase activity | 8.250321e-3 |
GO:0043252 | sodium-independent organic anion transport | 8.250321e-3 |
GO:0033631 | cell-cell adhesion mediated by integrin | 8.456606e-3 |
GO:0007168 | receptor guanylyl cyclase signaling pathway | 8.456606e-3 |
GO:0010172 | embryonic body morphogenesis | 8.530460e-3 |
GO:0043011 | myeloid dendritic cell differentiation | 8.535932e-3 |
GO:0045987 | positive regulation of smooth muscle contraction | 8.543663e-3 |
GO:0042058 | regulation of epidermal growth factor receptor signaling pathway | 8.698658e-3 |
GO:0032055 | negative regulation of translation in response to stress | 8.846872e-3 |
GO:0042321 | negative regulation of circadian sleep/wake cycle, sleep | 8.846872e-3 |
GO:0030241 | skeletal muscle myosin thick filament assembly | 8.846872e-3 |
GO:0021558 | trochlear nerve development | 8.846872e-3 |
GO:0042843 | D-xylose catabolic process | 9.008372e-3 |
GO:0051693 | actin filament capping | 9.176151e-3 |
GO:0009071 | serine family amino acid catabolic process | 9.223607e-3 |
GO:0060191 | regulation of lipase activity | 9.355781e-3 |
GO:0001954 | positive regulation of cell-matrix adhesion | 9.511945e-3 |
GO:0002455 | humoral immune response mediated by circulating immunoglobulin | 9.518639e-3 |
GO:0051044 | positive regulation of membrane protein ectodomain proteolysis | 9.522317e-3 |
GO:0071827 | plasma lipoprotein particle organization | 9.555917e-3 |
GO:0043117 | positive regulation of vascular permeability | 9.825335e-3 |
GO:0060707 | trophoblast giant cell differentiation | 9.898468e-3 |
GO:0045922 | negative regulation of fatty acid metabolic process | 1.020969e-2 |
GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin | 1.020969e-2 |
GO:0006544 | glycine metabolic process | 1.027952e-2 |
GO:0009069 | serine family amino acid metabolic process | 1.028388e-2 |
GO:0014015 | positive regulation of gliogenesis | 1.029323e-2 |
GO:0060591 | chondroblast differentiation | 1.029662e-2 |
GO:0002118 | aggressive behavior | 1.029662e-2 |
GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity | 1.029662e-2 |
GO:0050746 | regulation of lipoprotein metabolic process | 1.042409e-2 |
GO:0034445 | negative regulation of plasma lipoprotein particle oxidation | 1.046093e-2 |
GO:0002051 | osteoblast fate commitment | 1.046093e-2 |
GO:0045933 | positive regulation of muscle contraction | 1.051481e-2 |
GO:0034377 | plasma lipoprotein particle assembly | 1.052066e-2 |
GO:0031652 | positive regulation of heat generation | 1.059013e-2 |
GO:0003071 | renal system process involved in regulation of systemic arterial blood pressure | 1.067013e-2 |
GO:0009409 | response to cold | 1.069035e-2 |
GO:0042249 | establishment of planar polarity of embryonic epithelium | 1.076487e-2 |
GO:0048250 | mitochondrial iron ion transport | 1.076487e-2 |
GO:0002002 | regulation of angiotensin levels in blood | 1.076487e-2 |
GO:0034498 | early endosome to Golgi transport | 1.080300e-2 |
GO:0021530 | spinal cord oligodendrocyte cell fate specification | 1.080300e-2 |
GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly | 1.080300e-2 |
GO:0007386 | compartment pattern specification | 1.085289e-2 |
GO:0033121 | regulation of purine nucleotide catabolic process | 1.096711e-2 |
GO:0046835 | carbohydrate phosphorylation | 1.101025e-2 |
GO:0042398 | cellular modified amino acid biosynthetic process | 1.102014e-2 |
GO:0045777 | positive regulation of blood pressure | 1.119708e-2 |
GO:0043526 | neuroprotection | 1.125802e-2 |
GO:2000116 | regulation of cysteine-type endopeptidase activity | 1.129166e-2 |
GO:0035315 | hair cell differentiation | 1.131982e-2 |
GO:0016191 | synaptic vesicle uncoating | 1.131982e-2 |
GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.166166e-2 |
GO:0006690 | icosanoid metabolic process | 1.168610e-2 |
GO:0032321 | positive regulation of Rho GTPase activity | 1.180091e-2 |
GO:0042220 | response to cocaine | 1.202148e-2 |
GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process | 1.203529e-2 |
GO:0010893 | positive regulation of steroid biosynthetic process | 1.220610e-2 |
GO:0001991 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin | 1.227896e-2 |
GO:0071286 | cellular response to magnesium ion | 1.234801e-2 |
GO:0051546 | keratinocyte migration | 1.234801e-2 |
GO:0006564 | L-serine biosynthetic process | 1.234801e-2 |
GO:0044341 | sodium-dependent phosphate transport | 1.234801e-2 |
GO:0043280 | positive regulation of caspase activity | 1.245851e-2 |
GO:0014824 | artery smooth muscle contraction | 1.251341e-2 |
GO:0055119 | relaxation of cardiac muscle | 1.251341e-2 |
GO:0031440 | regulation of mRNA 3'-end processing | 1.272690e-2 |
GO:0046827 | positive regulation of protein export from nucleus | 1.272690e-2 |
GO:0021555 | midbrain-hindbrain boundary morphogenesis | 1.272690e-2 |
GO:0060678 | dichotomous subdivision of terminal units involved in ureteric bud branching | 1.302036e-2 |
GO:0071712 | ER-associated misfolded protein catabolic process | 1.302036e-2 |
GO:0060032 | notochord regression | 1.302036e-2 |
GO:0021930 | cerebellar granule cell precursor proliferation | 1.302036e-2 |
GO:0002352 | B cell negative selection | 1.302036e-2 |
GO:0006919 | activation of caspase activity | 1.317108e-2 |
GO:0019395 | fatty acid oxidation | 1.332061e-2 |
GO:0000266 | mitochondrial fission | 1.338550e-2 |
GO:0007199 | G-protein signaling, coupled to cGMP nucleotide second messenger | 1.344219e-2 |
GO:0032817 | regulation of natural killer cell proliferation | 1.349080e-2 |
GO:0034380 | high-density lipoprotein particle assembly | 1.353169e-2 |
GO:0009894 | regulation of catabolic process | 1.356195e-2 |
GO:0002739 | regulation of cytokine secretion involved in immune response | 1.356668e-2 |
GO:0043624 | cellular protein complex disassembly | 1.359177e-2 |
GO:0097084 | vascular smooth muscle cell development | 1.359242e-2 |
GO:0033239 | negative regulation of cellular amine metabolic process | 1.359242e-2 |
GO:0051642 | centrosome localization | 1.361164e-2 |
GO:0007007 | inner mitochondrial membrane organization | 1.362186e-2 |
GO:0035095 | behavioral response to nicotine | 1.364175e-2 |
GO:0043461 | proton-transporting ATP synthase complex assembly | 1.364175e-2 |
GO:0014807 | regulation of somitogenesis | 1.364175e-2 |
GO:0015722 | canalicular bile acid transport | 1.364175e-2 |
GO:0003270 | Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation | 1.364175e-2 |
GO:0043171 | peptide catabolic process | 1.395500e-2 |
GO:0006600 | creatine metabolic process | 1.429295e-2 |
GO:0019221 | cytokine-mediated signaling pathway | 1.439817e-2 |
GO:0050810 | regulation of steroid biosynthetic process | 1.447252e-2 |
GO:0006342 | chromatin silencing | 1.456248e-2 |
GO:2000392 | regulation of lamellipodium morphogenesis | 1.468030e-2 |
GO:0060327 | cytoplasmic actin-based contraction involved in cell motility | 1.468030e-2 |
GO:0016068 | type I hypersensitivity | 1.468030e-2 |
GO:0043163 | cell envelope organization | 1.468030e-2 |
GO:0007090 | regulation of S phase of mitotic cell cycle | 1.472714e-2 |
GO:0009082 | branched chain family amino acid biosynthetic process | 1.479141e-2 |
GO:0007522 | visceral muscle development | 1.479729e-2 |
GO:0034447 | very-low-density lipoprotein particle clearance | 1.489879e-2 |
GO:0034442 | regulation of lipoprotein oxidation | 1.489879e-2 |
GO:0060051 | negative regulation of protein glycosylation | 1.514092e-2 |
GO:0009051 | pentose-phosphate shunt, oxidative branch | 1.514092e-2 |
GO:0006680 | glucosylceramide catabolic process | 1.514092e-2 |
GO:0048172 | regulation of short-term neuronal synaptic plasticity | 1.516859e-2 |
GO:0060674 | placenta blood vessel development | 1.522952e-2 |
GO:0006071 | glycerol metabolic process | 1.529484e-2 |
GO:0060371 | regulation of atrial cardiomyocyte membrane depolarization | 1.541756e-2 |
GO:0046825 | regulation of protein export from nucleus | 1.543841e-2 |
GO:0046449 | creatinine metabolic process | 1.545948e-2 |
GO:0001516 | prostaglandin biosynthetic process | 1.564483e-2 |
GO:0072668 | tubulin complex biogenesis | 1.585675e-2 |
GO:0061077 | chaperone-mediated protein folding | 1.587261e-2 |
GO:0006749 | glutathione metabolic process | 1.591181e-2 |
GO:0044272 | sulfur compound biosynthetic process | 1.602415e-2 |
GO:0034501 | protein localization to kinetochore | 1.608362e-2 |
GO:0050713 | negative regulation of interleukin-1 beta secretion | 1.608362e-2 |
GO:0002309 | T cell proliferation involved in immune response | 1.608362e-2 |
GO:0010874 | regulation of cholesterol efflux | 1.630892e-2 |
GO:0060037 | pharyngeal system development | 1.645829e-2 |
GO:0048261 | negative regulation of receptor-mediated endocytosis | 1.647852e-2 |
GO:0032148 | activation of protein kinase B activity | 1.652461e-2 |
GO:0050901 | leukocyte tethering or rolling | 1.686669e-2 |
GO:0046514 | ceramide catabolic process | 1.686669e-2 |
GO:0048168 | regulation of neuronal synaptic plasticity | 1.689735e-2 |
GO:0008217 | regulation of blood pressure | 1.691702e-2 |
GO:0045684 | positive regulation of epidermis development | 1.702616e-2 |
GO:0060049 | regulation of protein glycosylation | 1.714270e-2 |
GO:0048144 | fibroblast proliferation | 1.714270e-2 |
GO:0006975 | DNA damage induced protein phosphorylation | 1.714270e-2 |
GO:0045079 | negative regulation of chemokine biosynthetic process | 1.714270e-2 |
GO:0060059 | embryonic retina morphogenesis in camera-type eye | 1.719508e-2 |
GO:0009074 | aromatic amino acid family catabolic process | 1.719508e-2 |
GO:0018410 | C-terminal protein amino acid modification | 1.720596e-2 |
GO:0034372 | very-low-density lipoprotein particle remodeling | 1.726061e-2 |
GO:0042274 | ribosomal small subunit biogenesis | 1.726892e-2 |
GO:0017196 | N-terminal peptidyl-methionine acetylation | 1.799941e-2 |
GO:0019428 | allantoin biosynthetic process | 1.799941e-2 |
GO:0051036 | regulation of endosome size | 1.799941e-2 |
GO:0032782 | bile acid secretion | 1.799941e-2 |
GO:0010725 | regulation of primitive erythrocyte differentiation | 1.799941e-2 |
GO:0006285 | base-excision repair, AP site formation | 1.799941e-2 |
GO:0000379 | tRNA-type intron splice site recognition and cleavage | 1.799941e-2 |
GO:0010616 | negative regulation of cardiac muscle adaptation | 1.799941e-2 |
GO:0003096 | renal sodium ion transport | 1.799941e-2 |
GO:0009637 | response to blue light | 1.799941e-2 |
GO:0046543 | development of secondary female sexual characteristics | 1.808478e-2 |
GO:0032980 | keratinocyte activation | 1.809784e-2 |
GO:0006669 | sphinganine-1-phosphate biosynthetic process | 1.809784e-2 |
GO:0006275 | regulation of DNA replication | 1.812775e-2 |
GO:0071205 | protein localization to juxtaparanode region of axon | 1.829912e-2 |
GO:0023021 | termination of signal transduction | 1.829912e-2 |
GO:0046670 | positive regulation of retinal cell programmed cell death | 1.835427e-2 |
GO:0071799 | cellular response to prostaglandin D stimulus | 1.835427e-2 |
GO:0050983 | deoxyhypusine biosynthetic process from spermidine, using deoxyhypusine synthase | 1.835427e-2 |